✨ Free AI Report
LeMaitre Vascular, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research LeMaitre Vascular, Inc.
Company Research

LeMaitre Vascular, Inc.: Business Overview, Financials & Competitive Analysis

LeMaitre Vascular, Inc. scores 8/10 on the AskCyborg Cyborg Score (Strong). Niche vascular device leader demonstrating double-digit organic growth, margin expansion, and disciplined capital allocation in a structurally growing market. LeMaitre reported a 16% increase in Q4 2025 sales and a 47% rise in operating income. The company forecasts 2026 revenue of $280 million with a 12% organic sales growth.

What is LeMaitre Vascular, Inc.'s industry? LeMaitre Vascular, Inc. (lemaitre.com) operates in Medical Devices - Vascular Surgery. AskCyborg classifies LeMaitre Vascular, Inc. under Medical Devices - Vascular Surgery in its company registry.

LeMaitre Vascular develops and manufactures specialized medical devices used by vascular surgeons to treat peripheral vascular disease and other circulatory conditions. The company operates across the Americas, Europe...

8/ 10Strong

Cyborg Score thesis

Niche vascular device leader demonstrating double-digit organic growth, margin expansion, and disciplined capital allocation in a...

Read the full analyst-debate transcript →
Industry Medical Devices - Vascular Surgery
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 19, 2026
AI-Generated Research
30+ Page Report

Get the Latest LeMaitre Vascular, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for LeMaitre Vascular, Inc.

AskCyborg analysts argue the bull and bear cases for LeMaitre Vascular, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
LeMaitre Vascular, Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

LeMaitre Vascular, Inc. Overview

Pro stress-test →

LeMaitre Vascular develops and manufactures specialized medical devices used by vascular surgeons to treat peripheral vascular disease and other circulatory conditions. The company operates across the Americas, Europe, EMEA, and APAC regions with a focused portfolio of proprietary biologic and synthetic vascular products.

Strategic Profile

Pro stress-test →

LeMaitre's 14% annualized revenue growth over the last five years was solid and beat the average healthcare company, showing its offerings resonate with customers. The company is positioned as a key player in the niche market of vascular surgery devices. Recent momentum is fueled by international expansion, particularly in EMEA and APAC regions, and strong product performance in high-margin categories.

Competitive Landscape

Pro stress-test →

LeMaitre competes in the specialized vascular surgery device market against larger diversified medical device companies like Medtronic and Stryker, as well as smaller niche competitors. LeMaitre's strong brand presence and portfolio of well-known products including Artegraft, XenoSure, and RestoreFlow are recognized for quality and reliability, which fosters customer loyalty and supports premium pricing strategies, with brand equity being a significant asset in a market where surgeon preference and product reputation drive purchasing decisions.

Industry Context

LeMaitre Vascular, Inc. operates in Medical Devices - Vascular Surgery.

Key facts

Founded: 1983 · Headquarters: Burlington, Massachusetts, US · Revenue: $250M (2025E) · Market cap: $2.45B

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on LeMaitre Vascular, Inc..

  • The company achieved a gross margin of 71.7%, with notable growth in product categories like grafts, valvulotomes, and shunts, with geographic improvements including EMEA up 29%, APAC 20%, and the Americas 10%.
  • A $100 million share repurchase program and a 25% dividend increase have been announced.
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • February 2026Q4 2025 beat on revenue and EPS with 16% sales growth and 47% operating income growth; raised FY2026 guidance
  • February 2026Increased quarterly dividend 25% to $0.25/share and announced $100M share repurchase program
  • +1 moreTrack every material event for LeMaitre Vascular, Inc. as it happens. Explore monitoring →
Get alerted when LeMaitre Vascular, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Vascular Access/Dialysis GraftsDiversified medical device leader with competing vascular graft offerings→Specialty Vascular DevicesCardiac and vascular surgery device manufacturer→Biologic GraftsEstablished manufacturer of vascular grafts and patches→

Compare LeMaitre Vascular, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

LeMaitre Vascular, Inc. operates in Medical Devices - Vascular Surgery. See how the rest of the sector scores on the Cyborg framework.

Browse Medical Devices - Vascular Surgery research →
NEW · MCP server

Ask your AI assistant about LeMaitre Vascular, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare LeMaitre Vascular, Inc. and its top competitor on Cyborg Score”
“What did LeMaitre Vascular, Inc. do this quarter?”
“Is LeMaitre Vascular, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com · Terms of Service

Frequently asked questions

What does LeMaitre Vascular, Inc. do?+
LeMaitre Vascular develops and manufactures specialized medical devices used by vascular surgeons to treat peripheral vascular disease and other circulatory conditions. The company operates across the Americas, Europe...
What is LeMaitre Vascular, Inc.'s Cyborg Score?+
LeMaitre Vascular, Inc. has a Cyborg Score of 8/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are LeMaitre Vascular, Inc.'s main competitors?+
Named competitors include Vascular Access/Dialysis Grafts, Specialty Vascular Devices, Biologic Grafts. The full competitive landscape is in the AskCyborg report.
How can I get the full LeMaitre Vascular, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the LeMaitre Vascular, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track LeMaitre Vascular, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.